Innovent Biologics says Jaypirca approved in China for new CLL/SLL indication
The approval covers chronic lymphocytic leukemia/small lymphocytic lymphoma across all lines of therapy.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.